+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Digital Therapeutics Market (2020-2025) By Application, Product and Sales Channel and Geography and the Impact of Covid-19 with Ansoff Analysis

  • ID: 5137778
  • Report
  • November 2020
  • Region: Global
  • 190 Pages
  • Infogence Global Research


  • 2morrow, Inc.
  • Livongo Health, Inc.
  • Medtronic Plc.
  • Omada Health, Inc.
  • Pear Therapeutics, Inc.
  • Voluntis, Inc.

Digital therapeutics are used to deliver evidence-based therapeutic interventions to patients. Digital therapeutics are managed by software programs to prevent, manage and treat a wide range of physical, mental and behavioral medical conditions. Digital therapeutics have the potential to enhance and support current healthcare system and fulfill the unmet medical needs.

Global Digital Therapeutics Market is expected to grow from USD 1.9 Bn in 2019 to USD 5.67 in 2025 at a CAGR of 20.0%.

Growth of the market is attributed to the increasing adoption of smartphones and tablets, rising focus on preventive healthcare, the need for controlling healthcare costs and increasing incidence of preventable chronic diseases.
The market is affected due to lack of awareness and access to the digital therapeutics in developing countries, data privacy concerns and resistance from traditional healthcare service providers. Unexplored therapeutic application and emerging markets offers huge growth opportunities for market players.

Market Dynamics

  • Increase in adoption of smartphones and tablets coupled with healthcare Apps
  • Rising focus on preventive healthcare
  • Need to control healthcare cost
  • Rising incidence of preventable chronic diseases

  • Lack of awareness and access to the Digital Therapeutics in Developing Countries
  • Patient Data Privacy concerns
  • Resistance from traditional healthcare service Providers

  • Unexplored Therapeutics Applications
  • Emerging Markets

Segments Covered
B2B segment holds the largest market share and is expected to grow at a highest CAGR. Increasing adoption by providers, buyers and employers due to the benefits of digital therapeutics has led to the dominance by the B2B segment.
North America accounts for the largest market share in the globe owing to the increasing investment in digital therapeutics, increase in the number of startups and government support. Furthermore, countries like Brazil and India have huge growth opportunities.

The Global Digital Therapeutics Market is segmented based on Application, Product, Sales Channel, and Geography

Global Digital Therapeutics Market, By Application
  • Introduction
  • Diabetes
  • Obesity
  • Cardiovascular diseases
  • Central nervous system (CNS) diseases
  • Gastrointestinal disorder
  • Respiratory diseases
  • Smoking cessation
  • Others

Global Digital Therapeutics Market, By Product
  • Introduction
  • Software
  • Devices

Global Digital Therapeutics Market, By Sales Channel
  • Introduction
  • Business-to-business (B2B)
  • Business-to-consumers (B2C)

Global Digital Therapeutics Market, By Geography
  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Company Profiles
Some of the companies covered in this report are 2morrow, Inc., Fitbit, Inc., Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Resmed, Inc., Voluntis, Inc., and Welldoc, Inc. etc.

IGR Competitive Quadrant
The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share etc.

Lions: Represents companies with a strong foothold in the market, with the highest market share, large investments in technologies, new products.
Bulls: Companies that are medium in size competing with their USPs, growing companies with proven market share.
Rabbits: Small companies but growing rapidly, constantly improving their offerings in the market.
Tortoise: Companies which are slow in growth, having a long legacy and stable or negative in performance.

Why buy this report?
The report offers a comprehensive evaluation of the Global Digital Therapeutics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys and observation of renowned personnel in the industry.
The report includes in-depth market analysis using Porter’s 5 force model and Ansoff Matrix. Impact of Covid-19 on the market is also featured in the report.
The report also contains the competitive analysis using IGR Competitive Quadrant, a Proprietary competitive positioning tool.

Report Highlights:
  • A complete analysis of the market including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Note: Product cover images may vary from those shown


  • 2morrow, Inc.
  • Livongo Health, Inc.
  • Medtronic Plc.
  • Omada Health, Inc.
  • Pear Therapeutics, Inc.
  • Voluntis, Inc.

1. Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2. Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Trends
5. Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6. Global Digital Therapeutics Market, By Application
6.1 Overview
6.2 Diabetes
6.3 Obesity
6.4 Cardiovascular diseases
6.5 Central nervous system (CNS) diseases
6.6 Gastrointestinal disorder
6.7 Respiratory diseases
6.8 Smoking cessation
6.9 Others
7. Global Digital Therapeutics Market, By Product
7.1 Overview
7.2 Software
7.3 Devices
8. Global Digital Therapeutics Market, By Sales Channel
8.1 Overview
8.2 Business-to-business (B2B)
8.3 Business-to-consumers (B2C)
9. Global Digital Therapeutics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 South America
9.3.1 Brazil
9.3.2 Argentina
9.4 Europe
9.4.1 UK
9.4.2 France
9.4.3 Germany
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Asia-Pacific
9.5.1 China
9.5.2 Japan
9.5.3 India
9.5.4 Australia
9.5.5 Rest of APAC
9.6 Middle East and Africa
10. Competitive Landscape
10.1 IGR Competitive Quadrant
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Mergers & Acquisitions
10.3.2 Agreements, Collaborations, & Partnerships
10.3.3 New Product Launches & Enhancements
10.3.4 Investments & Fundings
11. Company Profiles
11.1 2morrow, Inc.
11.2 Fitbit, Inc. (Twine Health, Inc.)
11.3 Livongo Health, Inc.
11.4 Medtronic Plc.
11.5 Omada Health, Inc.
11.6 Pear Therapeutics, Inc.
11.7 Proteus Digital Health, Inc.
11.8 Resmed, Inc. (Propeller Health)
11.9 Voluntis, Inc.
11.10 Welldoc, Inc.
12. Appendix
12.1 Questionnaire
Note: Product cover images may vary from those shown
  • 2morrow, Inc.
  • Fitbit, Inc. (Twine Health, Inc.)
  • Livongo Health, Inc.
  • Medtronic Plc.
  • Omada Health, Inc.
  • Pear Therapeutics, Inc.
  • Proteus Digital Health, Inc.
  • Resmed, Inc. (Propeller Health)
  • Voluntis, Inc.
  • Welldoc, Inc.
Note: Product cover images may vary from those shown